מדינה: ארצות הברית
שפה: אנגלית
מקור: NLM (National Library of Medicine)
TULATHROMYCIN (UNII: Q839I13422) (TULATHROMYCIN - UNII:Q839I13422)
Zoetis Inc.
TULATHROMYCIN
TULATHROMYCIN 25 mg in 1 mL
INTRAMUSCULAR
PRESCRIPTION
Swine DRAXXIN 25 Injectable Solution is indicated for the treatment of swine respiratory disease (SRD) associated with Actinobacillus pleuropneumoniae , Pasteurella multocida , Bordetella bronchiseptica , Haemophilus parasuis , and Mycoplasma hyopneumoniae ; and for the control of SRD associated with Actinobacillus pleuropneumoniae , Pasteurella multocida , and Mycoplasma hyopneumoniae in groups of pigs where SRD has been diagnosed. Suckling Calves, Dairy Calves, and Veal Calves BRD - DRAXXIN 25 Injectable Solution is indicated for the treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica , Pasteurella multocida , Histophilus somni , and Mycoplasma bovis . The use of DRAXXIN 25 Injectable Solution is contraindicated in animals previously found to be hypersensitive to the drug.
DRAXXIN 25 Injectable Solution is available in the following package sizes: 50 mL vial 100 mL vial 250 mL vial
New Animal Drug Application
DRAXXIN 25- TULATHROMYCIN INJECTION ZOETIS INC. ---------- DRAXXIN 25 (TULATHROMYCIN INJECTION) INJECTABLE SOLUTION ANTIBIOTIC 25 mg of tulathromycin/mL For use in suckling calves, dairy calves, veal calves, and swine. Not for use in ruminating cattle. CAUTION Federal (USA) law restricts this drug to use by or on the order of a licensed veterinarian. DESCRIPTION DRAXXIN 25 Injectable Solution is a ready-to-use sterile parenteral preparation containing tulathromycin, a semi-synthetic macrolide antibiotic of the subclass triamilide. Each mL of DRAXXIN 25 contains 25 mg of tulathromycin as the free base in a 50% propylene glycol vehicle, monothioglycerol (5 mg/mL), citric acid (4.8 mg/mL) with hydrochloric acid and sodium hydroxide added to adjust pH. DRAXXIN 25 consists of an equilibrated mixture of two isomeric forms of tulathromycin in a 9:1 ratio. The chemical names of the isomers are (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13- [[2,6- dideoxy-3-C-methyl-3--methyl-4-C-[(propylamino) methyl]---L-ribohexopyrano- syl]oxy]-2-ethyl-3,4,10-trihydroxy-3,5,8,10,12,14-hexamethyl-11-[[3,4,6-trideoxy-3- (dimethylamino)- -D-xylo-hexopyranosyl]-oxy]-1-oxa-6-azacyclopentadecan-15-one and (2R,3R,6R,8R,9R,10S,11S,12R)-11-[[2,6-dideoxy-3-C-methyl-3--methyl-4-C- [(propylamino)methyl]---L-ribohexopyrano-syl]oxy]-2-[(1R,2R)-1,2-dihydroxy-1- methylbutyl]-8-hydroxy-3,6,8,10,12-pentamethyl-9-[[3,4,6-trideoxy-3-(dimethylamino)- - D-xylohexopyranosyl]oxy]-1-oxa-4-azacyclotridecan-13-one, respectively. INDICATIONS SWINE DRAXXIN 25 Injectable Solution is indicated for the treatment of swine respiratory disease (SRD) associated with _Actinobacillus pleuropneumoniae_, _Pasteurella multocida_, _Bordetella bronchiseptica_, _Haemophilus parasuis_, and _Mycoplasma hyopneumoniae_; and for the control of SRD associated with _Actinobacillus pleuropneumoniae_, _Pasteurella_ _multocida_, and _Mycoplasma hyopneumoniae _in groups of pigs where SRD has been diagnosed. SUCKLING CALVES, DAIRY CALVES, AND VEAL CALVES BRD - DRAXXIN 25 Injectable Solution is in קרא את המסמך השלם